Previous 10 |
PALO ALTO, Calif. , Jan. 23, 2019 /PRNewswire/ -- First Quarter 2019 Summary – Oncology gross orders grew 16% in dollars, or 17% in constant currency – Total company revenues grew 9% in dollars, or...
ADTN , AZPN , BGG , BXS , CATY , CCI , CMRE , CNS , CP , CTXS , CVBF , F , FFBC , FFIV , HXL , LRCX , LVS , NXGN , PTC , RJF , SLG , SLM , STL , TCBI , TER , TRMK , TXN , UMPQ , URI , VAR , XLNX For Seeking Alpha's full earnings season calendar, clic...
Varian Medical Systems (NYSE: VAR ) is scheduled to announce Q4 earnings results on Wednesday, January 23rd, after market close. The consensus EPS Estimate is $1.07 (-7.8% Y/Y) and the consensus Revenue Estimate is $717.83M (-10.5% Y/Y). Over the last 2 years, VAR has beaten EPS estim...
PALO ALTO, Calif. , Sept. 12, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Jeffrey R. Balser , MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt University School of Medicine, has been appointed to the Varian...
SAN DIEGO , Sept. 12, 2018 /PRNewswire/ -- Epic Sciences (Epic) announced today that the company has completed a $52 million Series E financing led by Blue Ox Healthcare Partners, with participation by Deerfield Management and Varian (NYSE: VAR). Existing investors, including Alt...
PALO ALTO, Calif. and NAIROBI, Kenya , Sept. 7, 2018 /PRNewswire/ -- Varian (NYSE: VAR) signed a partnership agreement with Mediheal Group of Hospitals to expand access to radiotherapy in Kenya . This comprehensive partnership agreement includes the supply of advanced linear accel...
News, Short Squeeze, Breakout and More Instantly...
Varian Medical Systems Inc. Company Name:
VAR Stock Symbol:
NYSE Market:
Varian Medical Systems Inc. Website:
Varian Announces First Participant Treated in GENESIS II Clinical Trial of Genicular Artery Embolization for Knee Osteoarthritis PR Newswire PALO ALTO, Calif. , Nov. 17, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the...
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy PR Newswire – Results published in JAMA Oncology and presented at ASTRO dem...